Literature DB >> 22480970

Stevens-Johnson syndrome after treatment with bendamustine.

Matteo Lambertini, Lucia Del Mastro, Giovanni Gardin, Alessia Levaggi, Claudia Bighin, Sara Giraudi, Paolo Pronzato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22480970     DOI： 10.1016/j.leukres.2012.03.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine.

Authors:  Momoko Nishikori; Toshiyuki Kitano; Masayuki Kobayashi; Masakatsu Hishizawa; Toshio Kitawaki; Tadakazu Kondo; Kouhei Yamashita; Hiroshi Kawabata; Norimitsu Kadowaki; Yusuke Takei; Hironori Haga; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2015-04-02       Impact factor: 2.490

2.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

3.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.